GlaxoSmithKline agreed to buy a stake in Vir Biotechnology for $250m as part of a wider collaboration to development treatments for coronaviruses, including SARS-CoV-2, the...
RBC Capital Markets today downgrades its investment rating on Anglo American PLC (LON:AAL) to sector performer (from outperform) and cut its price target to 1500p...